Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1995;40(6):655-8.
doi: 10.1007/BF02818525.

Staphylococcus aureus in chronic and recurrent infections

Affiliations
Comparative Study

Staphylococcus aureus in chronic and recurrent infections

L Slobodníková et al. Folia Microbiol (Praha). 1995.

Abstract

Ninety-four Staphylococcus aureus strains isolated from chronic and recurrent skin and respiratory tract infections were investigated for several virulence factor expressions. Production of protein A was noticed in all of the tested strains in amounts from less than 0.1 to more than 2.5 ng per 10(6) bacterial cells. The percentage of the extracellularly produced protein A was found to lie between 4.5 and 27.8%. Two strains (both from the respiratory tract) produced more than 50% of protein A in the extracellular form and one strain did not produce any detectable amount of the extracellular protein A; 99% of the tested strains produced the clumping factor, 96% staphylocoagulase, 79% staphylokinase and 90% gelatinolytic activity; 79% produced alpha-toxin exclusively or in combination with delta- or beta-toxin; 8% of strains produced beta-toxin. There were differences in beta-toxin production between strains from the respiratory tract (5%) and skin infections (25%). delta-Toxin was produced by 53% of the strains. In each of the tested strains a complex of virulence factors was detected. The importance of inactivated extracellular products (especially alpha- and delta-toxin and in the case of skin infections also beta-toxin) as components of staphylococcal whole-cell vaccine was suggested.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1991 Jun;87(6):2236-45 - PubMed
    1. J Pathol Bacteriol. 1950 Oct;62(4):541-54 - PubMed
    1. Acta Ophthalmol Suppl. 1992;(202):42-6 - PubMed
    1. Infect Immun. 1989 Oct;57(10):3214-20 - PubMed
    1. Med Dosw Mikrobiol. 1987;39(2):83-93 - PubMed

Publication types

MeSH terms

LinkOut - more resources